Duphaston for pregnancy

It is estimated that more than 10 million pregnancies have been exposed to dydrogesterone. So far there were no indications of a harmful effect of dydrogesterone use during pregnancy.

Some progestogens have been reported in the literature to be associated with an increased risk of hypospadias. However due to confounding factors during pregnancy, no definitive conclusion can be drawn regarding the contribution of progestogens to hypospadias.Clinical studies, where a limited number of women were treated with dydrogesterone early in pregnancy, have not shown any increase in risk. No other epidemiological data are hitherto available.

Effects in non-clinical embryo-fetal and post-natal development studies were in line with the pharmacological profile. Untoward effects occurred only at exposures which exceeded the maximum human exposure considerably, indicating little relevance to clinical use.

Dydrogesterone can be used during pregnancy if clearly indicated.


No data exists on excretion of dydrogesterone in mother's milk. Experience with other progestogens indicates that progestogens and the metabolites pass to mother's milk in small quantities. Whether there is a risk to the child is not known. Therefore, dydrogesterone should not be used during the lactation period.


There is no evidence that dydrogesterone decreases fertility at therapeutic doses.

Pregnancy and Progesterone

Progesterone is considered generally safe to take during pregnancy. Regardless, you should tell your doctor if you are pregnant or might become pregnant before taking this or any other medication. You should also alert your physician if you are breastfeeding or plan to breastfeed.